Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Moodys
Queensland Health
Federal Trade Commission
Colorcon
Baxter
Cantor Fitzgerald
Argus Health
Dow

Generated: October 17, 2017

DrugPatentWatch Database Preview

Ibuprofen - Generic Drug Details

« Back to Dashboard

What are the generic sources for ibuprofen and what is the scope of ibuprofen patent protection?

Ibuprofen
is the generic ingredient in forty-four branded drugs marketed by Amneal Pharms, J And J Consumer Inc, Ani Pharms Inc, Bayer, Pfizer, Moberg Pharma North, Taro, Vintage Pharms, Marksans Pharma, Watson Labs, Sandoz, Sun Pharm Inds, Superpharm, LNK, Dr Reddys Labs Inc, Granules India Ltd, Aiping Pharm Inc, Perrigo R And D, Ohm Labs, Mcneil, Actavis Mid Atlantic, L Perrigo Co, Mcneil Ped, Purepac Pharm, Halsey, Par Pharm, Lederle, Strides Pharma, Contract Pharmacal, Northstar Hlthcare, Wyeth Cons, Amneal Pharms Ny, Bristol Myers, Aurolife Pharma Llc, Perrigo, P And L Dev Llc, Ivax Sub Teva Pharms, Teva, Mcneil Consumer, Basf, Mylan Pharms Inc, Hi-tech Pharmacal, Cumberland Pharms, Abbott, Alra, Mylan, Tris Pharma Inc, Avema Pharma, Dr Reddys La, OHM, Leiner, Pliva, Humanwell Puracap, Bionpharma Inc, Granules India, Merro Pharm, Sofgen Pharms, Exela Pharma Science, Recordati Rare, Pfizer Cons Hlthcare, Barr Labs Inc, Actavis Elizabeth, Forest Labs, and Dr Reddys Labs Ltd, and is included in two hundred and three NDAs. There are thirteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ibuprofen has thirty-nine patent family members in eleven countries.

There are sixty-four drug master file entries for ibuprofen. Two hundred and sixty-two suppliers are listed for this compound.

Summary for Generic Name: ibuprofen

US Patents:13
Tradenames:44
Applicants:64
NDAs:203
Drug Master File Entries: see list64
Suppliers / Packagers: see list262
Bulk Api Vendors: see list131
Clinical Trials: see list515
Patent Applications: see list9,606
Therapeutic Class:Anti-inflammatory Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ibuprofen at DailyMed

Pharmacology for Ingredient: ibuprofen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pliva
IBUPROFEN
ibuprofen
TABLET;ORAL071667-001Jun 18, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer
MIDOL
ibuprofen
TABLET;ORAL070591-001Sep 2, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
IBUPROFEN
ibuprofen
TABLET;ORAL070437-001Aug 21, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
IBUPROFEN
ibuprofen
TABLET;ORAL070493-001Dec 24, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Lederle
IBUPROFEN
ibuprofen
TABLET;ORAL070629-001Sep 19, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Ohm Labs
IBUPROHM
ibuprofen
TABLET;ORAL070469-001Aug 29, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Mcneil Ped
MOTRIN
ibuprofen
TABLET, CHEWABLE;ORAL020135-001Nov 16, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Taro
IBUPROFEN
ibuprofen
SUSPENSION;ORAL209204-001Jun 23, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Basf
IBU
ibuprofen
TABLET;ORAL070099-001Mar 29, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms Ny
IBUPROFEN
ibuprofen
TABLET;ORAL078558-002Jun 18, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ibuprofen

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Cons
CHILDREN'S ADVIL
ibuprofen
SUSPENSION;ORAL019833-002Sep 19, 1989► Subscribe► Subscribe
J And J Consumer Inc
CHILDREN'S MOTRIN
ibuprofen
TABLET, CHEWABLE;ORAL020601-001Nov 15, 1996► Subscribe► Subscribe
Mcneil Ped
MOTRIN
ibuprofen
TABLET, CHEWABLE;ORAL020135-002Nov 16, 1994► Subscribe► Subscribe
Mcneil Ped
MOTRIN
ibuprofen
TABLET, CHEWABLE;ORAL020135-002Nov 16, 1994► Subscribe► Subscribe
J And J Consumer Inc
CHILDREN'S MOTRIN
ibuprofen
SUSPENSION/DROPS;ORAL020603-001Jun 10, 1996► Subscribe► Subscribe
J And J Consumer Inc
CHILDREN'S MOTRIN
ibuprofen
SUSPENSION;ORAL020516-001Jun 16, 1995► Subscribe► Subscribe
Mcneil Ped
MOTRIN
ibuprofen
TABLET, CHEWABLE;ORAL020135-001Nov 16, 1994► Subscribe► Subscribe
J And J Consumer Inc
JUNIOR STRENGTH MOTRIN
ibuprofen
TABLET, CHEWABLE;ORAL020601-003Nov 15, 1996► Subscribe► Subscribe
Mcneil Ped
MOTRIN
ibuprofen
TABLET, CHEWABLE;ORAL020135-001Nov 16, 1994► Subscribe► Subscribe
Pfizer
CHILDREN'S ADVIL
ibuprofen
SUSPENSION;ORAL020589-001Jun 27, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: ibuprofen

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2005065674► Subscribe
Australia780212► Subscribe
Canada2767971► Subscribe
European Patent Office2405748► Subscribe
Australia7094900► Subscribe
European Patent Office2453742► Subscribe
China102791268► Subscribe
Japan2012523377► Subscribe
Germany60034044► Subscribe
World Intellectual Property Organization (WIPO)2011014208► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Covington
Boehringer Ingelheim
Deloitte
Novartis
Fish and Richardson
Colorcon
McKinsey
Accenture
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot